In randomized managed trials, There are 2 treatment choices at present considered the standard of care in Guillain-Barré syndrome (GBS). These contain either intravenous immunoglobulin (IVIG) or plasma exchange. IVIG https://bookmarkcork.com/story18927698/a-simple-key-for-guillain-barre-syndrome-physiotherapy-treatment-unveiled